A more interesting explanation is that pharma’s presence at the Super Bowl is about more than poor timing or mass market blockbusters. It might represent a sea change in how pharma is presenting ...

Bayer is vying to be first to market in the oral Factor XIa category against Bristol Myers Squibb and Johnson & Johnson, ...

Sam Possemiers, CEO of MRM Health, believes that the space is finally coming into maturity. At his own company, that’s in the ...

Telehealth company GoodRx said it is a "core integration partner" for TrumpRx, providing access to around 30 of Pfizer's ...

Pharma digital success is still largely defined by top level engagement metrics such as page visits, time on page, and ...

In June 2022, NHS England (NHSE) and the National Institute for Health and Care Excellence (NICE) launched the Innovative Medicines Fund (IMF). The £340 million fund will provide non-cancer patients ...

European biotechs continue to face a demanding investment climate characterised by investor caution. As a result, many are ...

Incubated by Flagship Pioneering, Generate applies AI to teasing out the three-dimensional structure of human proteins, ...

On Amgen's call, the company's head of R&D, Jay Bradner, said the FDA's request for a voluntary withdrawal on 16th January ...

A wireless sensor the size of a paperclip, Abbott's CardioMEMS HF, can be used routinely by the NHS to monitor patients with ...

Galleri is a multi-cancer early detection (MCED) or 'liquid biopsy' test that Grail says can spot signs of up to 50 different ...

Phase 2 results in advanced pancreatic cancer were presented at last year's ASCO cancer congress, and the live ...